ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

LMNX Luminex Corporation

36.99
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Luminex Corporation NASDAQ:LMNX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 36.99 36.94 36.98 0 01:00:00

Specialized Disclosure Report (sd)

30/05/2017 8:46pm

Edgar (US Regulatory)




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM SD

SPECIALIZED DISCLOSURE REPORT



LUMINEX CORPORATION
(Exact name of registrant as specified in its charter)


DELAWARE
 
000-30109
 
74-2747608
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)

12212 TECHNOLOGY BLVD., AUSTIN, TEXAS
 
78727
(Address of principal executive offices)
 
(Zip Code)


Harriss T. Currie
 
(512) 219-8020
(Name and telephone number, including area code, of the person to contact in connection with this report)
 


Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

x
 
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2016.









SECTION 1 - CONFLICT MINERALS DISCLOSURE

Item 1.01    Conflict Minerals Disclosure and Report

Luminex Corporation evaluated its current product lines and determined that certain products we manufacture contain tin, tungsten, tantalum and/or gold.

On June 30, 2016, we completed our acquisition of Nanosphere, Inc. (Nanosphere), a molecular diagnostic company that designs and sells diagnostic tools that enable detection of respiratory, gastroenteric and bloodstream infections. Nanosphere's products are included within the scope of this Form SD.

Conflict Minerals Disclosure

A copy of Luminex Corporation's Conflict Minerals Report is provided as Exhibit 1.01 hereto and is publicly available at www.luminexcorp.com/about-luminex/corporate-responsibility/ .

Item 1.02    Exhibit

As specified in Section 2, Item 2.01 of this Form SD, the Company is hereby filing its Conflict Minerals Report as Exhibit 1.01 to this report.


SECTION 2 - EXHIBITS

Item 2.01    Exhibits

Exhibit 1.01 - Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

Date: May 30, 2017
LUMINEX CORPORATION
 
 
 
 
 
By:  
/s/ Harriss T. Currie
 
 
Name:  
Harriss T. Currie 
 
 
Title:  
Chief Financial Officer, Senior Vice President of Finance 



1 Year Luminex Chart

1 Year Luminex Chart

1 Month Luminex Chart

1 Month Luminex Chart

Your Recent History

Delayed Upgrade Clock